ZA967281B - Polymorphs of the pro drug 6-N-(L-ALA-L-ALA)-trovafloxacin. - Google Patents

Polymorphs of the pro drug 6-N-(L-ALA-L-ALA)-trovafloxacin.

Info

Publication number
ZA967281B
ZA967281B ZA9607281A ZA967281A ZA967281B ZA 967281 B ZA967281 B ZA 967281B ZA 9607281 A ZA9607281 A ZA 9607281A ZA 967281 A ZA967281 A ZA 967281A ZA 967281 B ZA967281 B ZA 967281B
Authority
ZA
South Africa
Prior art keywords
ala
trovafloxacin
polymorphs
pro drug
pro
Prior art date
Application number
ZA9607281A
Other languages
English (en)
Inventor
Timothy Norris
James John Mcgarry
Douglas John Meldrum Allen
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA967281B publication Critical patent/ZA967281B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
ZA9607281A 1995-08-29 1996-08-28 Polymorphs of the pro drug 6-N-(L-ALA-L-ALA)-trovafloxacin. ZA967281B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US510995P 1995-08-29 1995-08-29

Publications (1)

Publication Number Publication Date
ZA967281B true ZA967281B (en) 1998-03-02

Family

ID=21714229

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9607281A ZA967281B (en) 1995-08-29 1996-08-28 Polymorphs of the pro drug 6-N-(L-ALA-L-ALA)-trovafloxacin.

Country Status (35)

Country Link
US (1) US6080756A (de)
EP (1) EP0847400B1 (de)
JP (1) JPH11509188A (de)
KR (1) KR100274736B1 (de)
CN (1) CN1193977A (de)
AP (1) AP639A (de)
AR (1) AR004507A1 (de)
AT (1) ATE208790T1 (de)
AU (1) AU696414B2 (de)
BR (1) BR9610283A (de)
CA (1) CA2230303C (de)
CO (1) CO4480740A1 (de)
CZ (1) CZ291524B6 (de)
DE (1) DE69617027T2 (de)
DK (1) DK0847400T3 (de)
DZ (1) DZ2088A1 (de)
ES (1) ES2164892T3 (de)
GT (1) GT199600061A (de)
HR (1) HRP960396A2 (de)
HU (1) HUP9900226A3 (de)
IL (1) IL122652A (de)
MA (1) MA23965A1 (de)
NO (1) NO309039B1 (de)
NZ (1) NZ310542A (de)
OA (1) OA10670A (de)
PL (1) PL185709B1 (de)
PT (1) PT847400E (de)
RU (1) RU2151152C1 (de)
SK (1) SK283354B6 (de)
TN (1) TNSN96110A1 (de)
TR (1) TR199800340T1 (de)
UA (1) UA48982C2 (de)
WO (1) WO1997008191A1 (de)
YU (1) YU48296A (de)
ZA (1) ZA967281B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000106A (es) 1997-08-01 1999-01-08 Pfizer Prod Inc Composiciones parenterales de alatroflaxacino
US6239141B1 (en) * 1999-06-04 2001-05-29 Pfizer Inc. Trovafloxacin oral suspensions
CN105510497A (zh) * 2015-11-30 2016-04-20 精晶药业股份有限公司 L-丙氨酰-l-丙氨酸的定量检测方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids

Also Published As

Publication number Publication date
KR100274736B1 (ko) 2000-12-15
ES2164892T3 (es) 2002-03-01
HRP960396A2 (en) 1998-04-30
NO309039B1 (no) 2000-12-04
YU48296A (sh) 1998-12-23
RU2151152C1 (ru) 2000-06-20
MA23965A1 (fr) 1997-04-01
WO1997008191A1 (en) 1997-03-06
PT847400E (pt) 2002-03-28
CA2230303A1 (en) 1997-03-06
PL325203A1 (en) 1998-07-06
EP0847400B1 (de) 2001-11-14
CZ55298A3 (cs) 1999-02-17
CA2230303C (en) 2001-07-24
NZ310542A (en) 1999-09-29
AP9600854A0 (en) 1996-10-31
SK283354B6 (sk) 2003-06-03
OA10670A (en) 2000-11-06
DE69617027T2 (de) 2002-03-21
CZ291524B6 (cs) 2003-03-12
IL122652A (en) 2000-01-31
EP0847400A1 (de) 1998-06-17
NO980863D0 (no) 1998-02-27
UA48982C2 (uk) 2002-09-16
HUP9900226A3 (en) 1999-11-29
US6080756A (en) 2000-06-27
AU696414B2 (en) 1998-09-10
AR004507A1 (es) 1998-12-16
DZ2088A1 (fr) 2002-07-22
TR199800340T1 (xx) 1998-06-22
HUP9900226A2 (hu) 1999-05-28
KR19990044231A (ko) 1999-06-25
CO4480740A1 (es) 1997-07-09
TNSN96110A1 (fr) 2005-03-15
JPH11509188A (ja) 1999-08-17
DK0847400T3 (da) 2002-03-25
IL122652A0 (en) 1996-08-16
PL185709B1 (pl) 2003-07-31
SK23798A3 (en) 1999-05-07
AU6135196A (en) 1997-03-19
DE69617027D1 (de) 2001-12-20
CN1193977A (zh) 1998-09-23
NO980863L (no) 1998-02-27
GT199600061A (es) 1998-01-31
MX9801665A (es) 1998-08-30
AP639A (en) 1998-04-14
ATE208790T1 (de) 2001-11-15
BR9610283A (pt) 1999-03-16

Similar Documents

Publication Publication Date Title
ZA967745B (en) Pharmaceutical formulations.
ZA969722B (en) Pharmaceutical formulations.
ZA96527B (en) Novel pharmaceutical combination
ZA965190B (en) Pharmaceutical composition.
ZA961444B (en) Pyrazolylbenzoyl derivatives.
CY2359B1 (en) Pharmaceutical formulation.
ZA961449B (en) Isoxazolylbenzoyl derivatives.
ZA969221B (en) Indolealkyl derivatives of benzodioxanmethylamine.
EP0850057A4 (de) Pharmazeutische zusammensetzungen
ZA968081B (en) Pharmaceutical composition.
CY2221B1 (en) N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
SG48455A1 (en) N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
ZA961884B (en) Novel naphthyl pharmaceutical compounds.
GB9508823D0 (en) Drug Derivatives
ZA968134B (en) The production of vitamin-containing solid formulations.
ZA962821B (en) 4-indolylpiperazinyl derivatives.
ZA967357B (en) Pyrazol-4-ylbenzoyl derivatives.
HUP9904181A3 (en) Sufrace-stabilised pharmaceutical preparation for application on the skin
ZA967281B (en) Polymorphs of the pro drug 6-N-(L-ALA-L-ALA)-trovafloxacin.
ZA9610589B (en) Pharmaceutical compounds.
ZA969021B (en) Use of cholecalciferol derivatives.
ZA964034B (en) N-aminopyridone derivatives.
ZA963753B (en) Synthesis of benzoquinolinones.
GB9526437D0 (en) Pharmaceutical compounds
GB9517867D0 (en) Pharmaceutical compounds